NASDAQ
Pharvaris N.V. - Ordinary Shares (PHVS)
♥ 375 Thanks from members
Pharvaris N.V. (PHVS) exhibits strong bullish sentiment, driven by its late-stage oral deucrictibant pipeline for angioedema, a bolstered cash position extending runway into 2028, and a favorable technical trend.